SEC Form 4 · accession 0000899243-19-005533
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Francis E Odonnell Jr.
Director
Period of report
Mar 1, 2019
Accepted (ET)
Mar 1, 2019 · 6:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2019 | M | 46,000 | $0.00 | A | 544,187 | D | |
| Common StockF3 | Mar 1, 2019 | S | 23,000 | $5.07 | D | 521,187 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | $0.00 | Mar 1, 2019 | M | 46,000 | D | — | Mar 1, 2019 | Common Stock | 46,000 | 0 | D |
Explanation of responses
- F1The shares of common stock were acquired by the Reporting Person as a result of the vesting of 46,000 of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 29, 2016 under the Issuer's 2011 Equity Incentive Plan, as amended.
- F2The shares of common stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs.
- F3On March 1, 2019, the Reporting Person sold an aggregate of 23,000 shares of the Issuer's Common Stock at a weighted average price of $5.07 per share. The highest sale price for the Common Stock was $5.20 per share and the lowest sale price was $4.90 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.